The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2015
Filed:
Nov. 17, 2010
Applicants:
Raphael Schiffmann, Rockwall, TX (US);
Fanny Mochel, Dallas, TX (US);
Lawrence Sweetman, Heath, TX (US);
Sabrina Forni, Dallas, TX (US);
Inventors:
Raphael Schiffmann, Rockwall, TX (US);
Fanny Mochel, Dallas, TX (US);
Lawrence Sweetman, Heath, TX (US);
Sabrina Forni, Dallas, TX (US);
Assignee:
Baylor Research Institute, Dallas, TX (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/33 (2006.01); A61K 31/445 (2006.01); A61B 10/00 (2006.01); G01N 30/88 (2006.01);
U.S. Cl.
CPC ...
A61K 31/445 (2013.01); A61B 10/0051 (2013.01); A61B 10/0058 (2013.01); A61B 10/007 (2013.01); A61B 2010/0061 (2013.01); G01N 2030/8831 (2013.01);
Abstract
The present invention describes a method for determination of urinary globotriaosylceramide (Gb3) levels in non-Fabry disease cardiac patients. Determination of Gb3 levels provides a screening method for determining cardiac risk and may offer an alternative therapeutic option for cardiac disease management or cardiac disease risk mitigation by lowering Gb3 levels by the use of pharmacological chaperones or other agents.